Patient experience data in regulatory decisions: Questions abound in first FDA report

The FDA on Tuesday released its first report on the use of patient experience data in approval decisions, although it makes clear there’s a lot of work to do on this front as applicants, patients, and caregivers said they do not fully understand how FDA uses this data in its approval process.